Burrows Scott L Insider Trades & Stock Holdings

Chief Financial Officer · Spyre Therapeutics, Inc. · Latest filing Oct 1, 2026

Burrows Scott L, Chief Financial Officer at Spyre Therapeutics, Inc. has 2 Form 4 trades on file since Sep 30, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($2.26M), net -$2.26M. Latest filing: disposed of 7.50K shares of $SYRE on Oct 1, 2026 at $91.83.

Trades on file

2

Open-market bought

$0

Open-market sold

$2.26M

Net open-market

-$2.26M

Latest filing

Oct 1, 2026

All insider trades by Burrows Scott L

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 1, 2026	$SYRE	Sell (Open-market sale) 10b5-1	7.50K	$91.83	$688.76K			-11.2%			Chief Financial Officer		—
Sep 30, 2026	$SYRE	Sell (Open-market sale) 10b5-1	17.50K	$89.89	$1.57M			-9.2%			Chief Financial Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Burrows Scott L traded

• $SYRE

Frequently asked questions

Has Burrows Scott L been buying or selling stock?

Burrows Scott L has 0 open-market purchases and 2 open-market sales on file, net -$2.26M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Burrows Scott L's latest insider trade?

disposed of 7.50K shares of $SYRE on Oct 1, 2026 at $91.83.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.